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Abstract
Introduction: Myocardial infarction (MI) is a well-recognized clinical entity with a worldwide
distribution. In the United States alone, 1.5 mfflion cases of MI occur per year. This study compares the
in-hospital mortality, 1 year mortality and time to death following a first Q-wave or non Q-wave
myocardial infarction (MI).
Methods: One thousand five hundred and ninety-six patients were admitted at the Aga Khan
University Hospital with a diagnosis of MI over a period of four years of whom 420 patients met our
inclusion criteria. Data was collected from the patients’ medical records and on telephone using a
pretested questionnaire. Logistic regression and Cox proportional hazard models were used to analyze
the data.
Results: The mean age ±sd of the patients was 59±10 years. Of the total patients, 151(36%) and
269(64%) suffered non-Q wave and Q-wave MI respectively. A higher in hospital mortality was
observed in patients with Q-wave MI (n64, 23.8%) than those with non-Q wave MI (n=16 (10.6%);
adjusted OR = 2.76, 95% CI:1.5-5.01}. Similarly, patients having Q-wave Ml experienced increased 1
year mortality (n=77, 28.6%) compared to patients suffering non-Q wave MI {n=26 (17.2%); adjusted
OR = 2.04,95% CI: 1.21-3.43}.
Conclusion: Patients with Q-wave MI had a worse prognosis compared with patients with non-Q-wave
MI and therefore warrant a closer follow up. Further prospective studies are needed to evaluate the
efficacy of early aggressive interventions in modifying the natural history of this disease (JPMA
49:149, 1999).
Introduction
Myocardial infarction (MI) is a well-recognized clinical entity with a worldwide distribution. The
World Health Organization defmes MI as a diagnosis when two of the following triad is present:
clinical symptoms (i.e.: typical chest pain), cardiac enzyme elevation and ECG changes1. In the United
States alone, 1.5 million cases of MI occur per year2. The overall prevalence of coronary heart disease
in India was between 32-45/1000 people in different communities, and the prevalence of Ml varied
between 10-15/1000 people3,4. Infarction has previously been classified as transmural if ST elevation
or Q waves were observed in ECG or sub-endocardial if typical chest pain, creatine phosphokinase
(CPK) enzyme elevation, and ST-T wave changes occurred in the absence of flew Q waves. However
on pathological examination, most infarctions involve the subendocardium and some transmurai
extension is common even in the absence of Q waves on ECG. Thus a more appropriate classification
was devised, based on the presence or absence of Q waves5.
The well-established risk factors for MI include old age, male gender, smoking, diabetes, hypertension,
hypercholestrolemia and the presence or family history of ischemic heart disease6. Previous studies

have shown a higher incidence of non-Q wave MI in the elderly and fema!es7,8,9. Several studies
looked at differences between the two types of infarction regarding prevalence of hypertension,
smoking, diabetes, hypercholestrolemia and family history of ischemic heart disease10-13. None found
any difference in the distribution of these risk factors between the two types of infarctions. Stone et al8,
however reported an increased frequency of diabetes in people suffering non-Q wave infarctions. The
Framingham14 study reported a higher incidence of hypertension in non-Q wave myocardial infarction
group. A history of hypertension remains predictive of adverse outcome, particularly short-term
mortality15. For patients less than 65 years of age, hypertension is a moderate risk factor for !ong term
mortality16. Diabetic patients had a higher mortality at 28 days post MI17. Cigarette smoking did not
show a quantitative relationship with the severity of the acute infarction in terms of short and long term
mortality18.
The prognosis after myocardial infarction depends on the infarct size, as demonstrated by the CK levels
in blood, left ventricular function, and the use of thrombolytic therapy19,20. Studies have shown that
patients with non Q wave MI suffered smaller infarcts, as reflected by lower CPK levels21,22, and
higher post MI left ventricular ejection fraction8,22.
People suffering Q wave infarction usually experience higher in hospital mortality. However there is no
difference in long term survival when compared to non-Q wave MI8,14,23 This is controversial, and
studies showing no difference regarding in hospital mortality21,22, and reduced long term survival for
non Q wave infarctions have also been reported24-26.
It has been shown that the total in hospital and 6 month mortality was lower in patients younger than 50
years than those above 50 years27,28. In one study, gender did not affect in-hospital and three-year
mortality rates29.
Other studies have demonstrated a higher short-term mortality in women but similar long-term
mortality30,31.
Existing literature holds much controversy regarding the prognosis of patient with Q wave and non Q
wave infarctions. Therefore, we conducted this study to compare the in hospital mortality, mortality at I
year and the time to death in association with the various risk factors proven to have a role in
myocardial infarction.
Materials and Methods
Patients
A retrospective cohort of patients admitted at the Aga Khan: University Hospital (AKUH), a tertiary
care hospital between January 1, 1994 and December 31, 1997 with a diagnosis of Ml was eligible for
inclusion in the study. A total of 1596 patients were identified by the indexing and coding department
AKUH, of whom 272 died in hospital while 1324 were discharged. Patients were excluded from the
study if they had a prior MI, a preexisting left bundle branch block on ECG, history of prior
revascularization(i.e. coronary artery bypass grafting and coronary angioplasty) and if telephone
contact was not possible. Patients were telephoned in order to determine their survival status until 1st
Jan 1999. The final study sample included 420 patients of whom 80 died in hospital while 340 survived
their hospital stay and were interviewed via phone.
Congestive heart failure was taken as documented by the attending physician and/or diffuse bilateral
rales on chest auscultation and/or evidence of pulmonary edema on chest X-ray and/or presence of S3
on auscultation. A cardiologist (AA) using the Minnesota code criteria32 determined the type of infarct
for Q-wave Ml.
Data management and analysis

The SPSS software package was used for data entry and analysis. Age was categorized into quartiles
and used in subsequent analysis. Patients with Q-wave Ml were compared with those suffering non Qwave Ml with regard to demographic and clinical variables. The student’s t-test or chi-square test was
used as appropriate.
In-hospital mortality, mortality at 1 year follow-up and time to death during follow-up were the three
outcome variables used in this study. Unadjusted relationship of infarct type (i.e. Q-wave or non Qwave) with in-hospital mortality and mortality at 1 year was assessed by simple logistic regression.
Univariate logistic regression was used to identify potential confounding factors from gender, sex,
history of hypertension, diabetes mellitus, smoking and family history of ischemic heart disease.
Factors related with the three outcome variables were incorporated multivariable analysis (P 0.2). The
final models for ‘in-hospital mortality’ and ‘mortality at 1 year’ were selected through backward
stepwise procedure and included factors which were significantly (P <0.05) related to these outcome
variables.
Unadjusted survival experience over the study duration was estimated using the Kaplan Meier method
to discharge were examined using Cox proportional hazard model. The independent variables
considered were the same as for in-hospital mortality and mortality at 1 year.
Results
Table 1 describes the baseline characteristics of patients presenting with Q wave and non Q wave Ml.
Patients with Q-wave MI were significantly more likely to have family history of ischemic heart
disease (p = 0.026), higher mean CK (p < 0.0001) and receive thrombolytic therapy (p<0.001). The two
groups however, did not differ significantly in age, gender. history of smoking, history of diabetes,
history of hypertension and congestive heart failure in hospital (Table 1).

In-Hospital Mortality
Eighty patients died during the course of their hospital stay. Amongst 269 patients who suffered Q
wave MI, 64(23.8%) died whereas only 16(10.6%) out of 151 patients suffering from non-Q wave MI
expired, during their hospital stay.
The final multivariable logistic regression model for in-hospital mortality (Table 2)

demonstrated that age, smoking and infarct type significantly affected outcome. After adjusting for
confounders, it was seen that Q-wave Ml patients were more likely to suffer from in-hospital mortality
than non-Q wave MI patients (adjusted OR = 2.76, 95%C1 1.5 - 5.01, p 0.001). Smoking had a
protective effect on in-hospital mortality (adjusted OR = 0.24, 95%C1 0. 12-0.48, p <0.001). Patients
over 67 year of age had increased likelihood of dying during hospital stay compared to patients aged 49
years (adjusted OR = 3.81; 95%Cl: 1.54-9.47. p = 0.004).
Mortality at 1 Year
One year after experiencing their first Ml, 103 patients died. This constituted 77(28.6%) of patients
with Q wave Ml and 26 (17.2%) of patients with non-Q wave Ml. The final multivariate logistic
regression model (Table 3)

demonstrated that age, smoking and infarct type, significantly affected I-year mortality. Patients with
Qwave infarction experienced increased mortality at 1 year follow-up than patients with non- Q wave
infarctions (OR = 2.04; 95%Cl 1.21-3.43, p = 0.0076). Smoking had a protective effect on 1 year
mortality (OR 0.34, 95%Cl: 0.19-0.6, p = 0.0002). Patients aged 59-66 years were 2.95 times more
likely to die with in 1 year compared to patients 49 years (adjusted OR = 2.95, 95% Cl: 1 .23-7.06, p =
0.015). Patients >. 67 years of age had an even higher odds of dying within 1 year after first Ml
(adjusted OR = 5.18; 95% Cl: 2.22-12.1, p = 0.0001).
Time to death following hospitalization
The median time to death following the diagnosis of MI was 6 days. Med ian survival time of the
patients who died after suffering from non-Q wave Ml and Q-wave Ml was 61 days and 4 days
respectively (Figure).

The final multivariate Cox proportional hazard model (Table 4)

demonstrated that age, smoking, revascularization and infarct type, significantly affected time to death
following diagnosis of Ml. After adjusting for confounders, the relationship between infarct type and
time to death was marginally significant (adjusted RH = 1.45, 95% Cl: 0.98-2.12, p = 0.06).
Revascularization (adjusted RH = 0.18; 95%Cl: 0.08-0.42, p = 0.0001) and smoking history (adjusted
RH 0.43, 95% CI: 0.28-0.67, p = 0.0002) prolonged survival following first diagnosis of Ml among the
study subjects. Patients above 67 years were 2.1 times more likely to die during the total follow-up
period than patients below 49 years (adjusted RH = 2.1; 95% Cl: 1.2-3.8, p = 0.01).

Discussion
This data demonstrates important differences in baseline characteristics and clinical outcome between
patients presenting with first Q wave and non-Q wave MI. Majority of the risk factors associated with
MI did not show a statistically significant difference in their distribution between Q wave and non-Q
wave Ml. This is consistent with data from previous studies10,11 CoIl et al12 showed that patients with
non Q wave Ml were significantly younger. On the other hand Nicod et al observed that patients with
non-Q wave MI were significantly older7. However he had excluded patients in whom location of
infarct could not be determined.
Stone et al observed more diabetics in the group of patients with non-Q wave MI8. In our study sample,
family history of IHD was found more frequently in patients with Q wave MI. A higher CK peak value
was also found in Q wave vs non-Q wave MI. This is consistent with previous studies23,24. The
biological rationale underlying this observation is that patients with non-Q wave Ml’s often exhibit
partial coronary occlusion in the infarct territory. On the other hand, patients with Q wave Ml’s often
have total coronary artery occlusion in the infarct territory. This leads to increased infarct size and thus
higher peak CK levels33,34.
Multivariate analysis indicates that Q wave Ml patients have higher in-hospital mortality than non-Q
wave MI patients, with a similar trend being observed for 1 year mortality. This finding corroborates
the results of many recent studies19,20,25,26. Regarding long term mortality, patients with Q wave Ml
exhibited marginally increased mortality than patients with non-Q wave MI (OR = 1.45, 95% Cl 0.98 2). However, much controversy surrounds this issue, since literature is available suggesting that Q
wave and non Q wave Ml patients have similar short term20 and long term survival8. However, it
should be noted that these studies also included patients with previous MI8,21 used only univariate
analysis21 and excluded a subgroup of patients having antero-inferior MI8.
Smoking had a beneficial effect on survival in in-hospital mortality. This finding is supported by
previous literature34. The biological rationale for this effect is that smokers develop occlusive coronary
thrombi at an earlier stage of atherosclerosis than in non-smokers. Thus, left ventricular function is
relatively well preserved following MI in smokers, owing to the less advanced stage of coronary
atherosclerosis. Hence, in-hospital mortality is lower in smokers compared to non-smokers. However,
smokers tend to suffer a higher frequency of reinfarctions, which reduces their long-term survival34.
The results show a protective effect of smoking on mortality at 1-year follow up as well as for time to
death following discharge from hospital. This may be explained by the limited follow-up period of this
study.
Patients over 67 years of age had increased risk of dying than patients below 50 years of age for in
hospital mortality, I-year mortality and early death following discharge. This is supported by Mocetti et
at29 who also showed a higher in hospital and 6 month mortality in patients above 70 years.
In conclusion, patients with first Q-wave MI had a worse prognosis than patients with non Q wave MI.
Hence they warrant a closer follow-up and aggressive risk reduction measures. Additional planned
prospective studies are needed to evaluate whether early aggressive intervention may beneficially
modify the natural history of this disease.
Limitations of the study
Although multivariate analysis was used to adjust for prognostic factors affecting survival after Ml (Q
wave v/s. non Q-wave), medications given to patient after hospital discharge could modify the longterm outcome. Such data was not reliably available for many subjects and were therefore, not included
in the analysis. Records did not contain adequate data for quantifying time lag between symptom onset
and hospital presentation of MI patients. Therefore, the peak CK levels may not be a reliable estimate

of the actual infarct size in these patients. Another limitation of the study was that the cause of death
could not be ascertained on telephonic interview. For that reason, all cause mortality was used.
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